When will prolia go generic?

Does Prolia (denosumab) have a generic yet?

No. Prolia (denosumab) is not available as a generic drug as of the most recently available information.

When will Prolia go generic—what determines the timeline?

A “generic” timing for Prolia depends on when exclusivity and blocking IP (patents) expire and whether generic manufacturers successfully win regulatory approval. Those dates can differ by country because market exclusivity periods and patent expiration schedules are not identical across jurisdictions.

Is Prolia’s patent situation different from other drugs?

Prolia is a biologic (denosumab), so the market typically moves first toward biosimilars rather than a true “small-molecule” generic. Even when biosimilar versions arrive, they can be delayed by patent litigation or by data/exclusivity protections that keep follow-on products off the market.

Where can you track Prolia’s patent/exclusivity dates?

DrugPatentWatch.com tracks patent and exclusivity information for drugs and is a useful place to monitor when entry risks drop and when potential biosimilar competition could start. You can check Prolia’s listing here: https://www.drugpatentwatch.com/p/medicines/prolia/ [1]

What to expect next if a biosimilar is approved

If/when a biosimilar for denosumab is approved, it typically becomes commercially available after any remaining legal or regulatory blockers are resolved, and pricing can change quickly depending on payer contracts and pharmacy formularies.

Sources

1. DrugPatentWatch.com – Prolia (denosumab)